ZA200707523B - Purification of rapamycin - Google Patents

Purification of rapamycin

Info

Publication number
ZA200707523B
ZA200707523B ZA200707523A ZA200707523A ZA200707523B ZA 200707523 B ZA200707523 B ZA 200707523B ZA 200707523 A ZA200707523 A ZA 200707523A ZA 200707523 A ZA200707523 A ZA 200707523A ZA 200707523 B ZA200707523 B ZA 200707523B
Authority
ZA
South Africa
Prior art keywords
rapamycin
purification
Prior art date
Application number
ZA200707523A
Other languages
English (en)
Inventor
Chia-Cheng Shaw
Warren Chew
Bogdan Wilk
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ZA200707523B publication Critical patent/ZA200707523B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200707523A 2005-03-02 2007-08-31 Purification of rapamycin ZA200707523B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65791005P 2005-03-02 2005-03-02

Publications (1)

Publication Number Publication Date
ZA200707523B true ZA200707523B (en) 2010-02-24

Family

ID=36568679

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707523A ZA200707523B (en) 2005-03-02 2007-08-31 Purification of rapamycin

Country Status (15)

Country Link
US (1) US7384953B2 (zh)
EP (1) EP1853612A1 (zh)
JP (1) JP2008531686A (zh)
KR (1) KR20070107087A (zh)
CN (1) CN101133065A (zh)
AU (1) AU2006218918A1 (zh)
CA (1) CA2599582A1 (zh)
CR (1) CR9297A (zh)
IL (1) IL185077A0 (zh)
MX (1) MX2007010716A (zh)
NI (1) NI200700225A (zh)
NO (1) NO20074102L (zh)
RU (1) RU2007130406A (zh)
WO (1) WO2006093745A1 (zh)
ZA (1) ZA200707523B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0313024A (pt) 2002-07-30 2005-07-12 Wyeth Corp Formulações parenterais contendo um hidroxiéster de rapamicina
JP2010509317A (ja) * 2006-11-10 2010-03-25 バイオコン リミテッド 純粋な形態のラパマイシンならびにこの回収方法および精製方法
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US20080175887A1 (en) 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
WO2010024898A2 (en) 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US20120183531A1 (en) 2009-07-14 2012-07-19 Biogen Idee Ma Inc Methods for Inhibiting Yellow Color Formation in a Composition
CN102443012B (zh) * 2010-10-13 2016-03-02 鲁南制药集团股份有限公司 一种从发酵液中提纯雷帕霉素的方法
CN103705925B (zh) 2012-09-29 2018-03-30 段磊 抑制PI3K/AKT/mTOR信号通路的药物组合
US9750728B2 (en) 2012-09-29 2017-09-05 Targeted Therapeutics, Llc Method and pharmaceutical composition for inhibiting PI3K/AKT/mTOR signaling pathway
ES2897473T3 (es) 2013-03-15 2022-03-01 Biosensors Int Group Ltd Purificación de derivados de la rapamicina
MX2016004530A (es) 2013-10-08 2017-02-13 Lam Therapeutics Inc Rapamicina para el tratamiento de linfangioleiomiomatosis.
PL3125875T3 (pl) * 2014-04-04 2023-11-20 AI Therapeutics, Inc. Nadający się do inhalacji preparat rapamycyny do leczenia stanów związanych z wiekiem
EP3209330B1 (en) 2014-10-07 2022-02-23 AI Therapeutics, Inc. An inhalable sirolimus formulation for the treatment of pulmonary hypertension
WO2016130645A1 (en) 2015-02-10 2016-08-18 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
WO2018031789A1 (en) 2016-08-10 2018-02-15 The Board Of Regents Of The University Of Texas System Topical rapamycin therapy
CN109369680A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种依维莫司的纯化方法
CN109485657A (zh) * 2018-12-24 2019-03-19 江苏卓和药业有限公司 一种替西罗莫司的纯化方法
CN109369679A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种雷帕霉素的精制方法
EP3927319A1 (en) 2019-02-20 2021-12-29 AI Therapeutics, Inc. Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993749A (en) * 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) * 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
CA2528173A1 (en) 2003-07-16 2005-02-03 Wyeth Cci-779 isomer c
DK1658295T3 (da) 2003-08-07 2007-09-24 Wyeth Corp Regioselektiv syntese af CCI-779

Also Published As

Publication number Publication date
MX2007010716A (es) 2008-01-16
RU2007130406A (ru) 2009-04-10
US7384953B2 (en) 2008-06-10
CR9297A (es) 2008-01-21
IL185077A0 (en) 2007-12-03
CA2599582A1 (en) 2006-09-08
KR20070107087A (ko) 2007-11-06
AU2006218918A1 (en) 2006-09-08
JP2008531686A (ja) 2008-08-14
NI200700225A (es) 2008-07-03
CN101133065A (zh) 2008-02-27
EP1853612A1 (en) 2007-11-14
NO20074102L (no) 2007-09-26
US20060199954A1 (en) 2006-09-07
WO2006093745A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
IL185077A0 (en) Purification of rapamycin
HRP20150012T1 (en) 39-desmethoxy derivatives of rapamycin
IL187361A0 (en) Methods of purifying tigecycline
EP1970024A4 (en) SYSTEM OF FULLY ADJUSTABLE LATCHES
IL185757A0 (en) Methods of decreasing calcifcation
IL187949A0 (en) Diastereomeric purification of rosuvastatin
GB0608190D0 (en) Method of purification
HK1161122A1 (zh) 的用途
HK1122797A1 (en) Derivatives of pyrido
GB0503942D0 (en) Purification process
ZA200802893B (en) Purification of water
GB0523257D0 (en) Purification process
IL184570A0 (en) Purification of oligonucleotides
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
EP1904644A4 (en) DETECTION OF MICROORGANISMS
IL184188A0 (en) Process of purifying tadalafil
GB0512459D0 (en) Removal of nitrogen compounds
GB0508439D0 (en) Design of structural elements
GB0602509D0 (en) Acetonitrile purification
GB0508200D0 (en) Purification of nanostructures
GB0506164D0 (en) Purification of salts
HUP0500461A3 (en) Pyperazine derivatives of alkyl-oxindoles
GB0510013D0 (en) Interaction of SNEV
GB0512942D0 (en) Detection of bodies
GB0503270D0 (en) Purification filter